Next Article in Journal
Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents
Next Article in Special Issue
Histological Subtypes Drive Distinct Prognostic Immune Signatures in Classical Hodgkin Lymphoma
Previous Article in Journal
Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis of Clinical Trial Demographics
Previous Article in Special Issue
The Grey Zones of Classic Hodgkin Lymphoma
 
 
Commentary

Article Versions Notes

Cancers 2022, 14(17), 4063; https://doi.org/10.3390/cancers14174063
Action Date Notes Link
article xml file uploaded 23 August 2022 08:40 CEST Original file -
article xml uploaded. 23 August 2022 08:40 CEST Update https://www.mdpi.com/2072-6694/14/17/4063/xml
article pdf uploaded. 23 August 2022 08:40 CEST Version of Record https://www.mdpi.com/2072-6694/14/17/4063/pdf
article html file updated 23 August 2022 08:41 CEST Original file -
article html file updated 24 August 2022 21:28 CEST Update https://www.mdpi.com/2072-6694/14/17/4063/html
Back to TopTop